Wednesday, September 10, 2008

What Mystery Buyer Would Pay $70 Per Share for ImClone?

Rejecting a $60 per share offer from Bristol-Myers Squibb, ImClone says a $70 offer from an unnamed drug company may be imminent.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)